SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-061044
Filing Date
2012-11-13
Accepted
2012-11-13 06:17:41
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v326306_10q.htm 10-Q 460920
2 EXHIBIT 31.1 v326306_ex31-1.htm EX-31.1 9534
3 EXHIBIT 32.1 v326306_ex32-1.htm EX-32.1 3777
  Complete submission text file 0001144204-12-061044.txt   5182365

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT lixt-20120930.xml EX-101.INS 651912
5 XBRL TAXONOMY EXTENSION SCHEMA lixt-20120930.xsd EX-101.SCH 73352
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lixt-20120930_cal.xml EX-101.CAL 26240
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lixt-20120930_def.xml EX-101.DEF 230424
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lixt-20120930_lab.xml EX-101.LAB 412370
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lixt-20120930_pre.xml EX-101.PRE 280500
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 121195351
SIC: 2834 Pharmaceutical Preparations